Detalles de la búsqueda
1.
Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer.
Future Oncol
; 16(32): 2661-2672, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805138
2.
Immunotherapy in breast cancer.
J Carcinog
; 18: 2, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31160888
3.
Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer.
J Carcinog
; 18: 5, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949426
4.
Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.
Breast Cancer Res Treat
; 158(1): 113-126, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27283835
5.
Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer.
Psychosom Med
; 78(1): 26-37, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26569533
6.
Ethnic differences in types of social support from multiple sources after breast cancer surgery.
Ethn Health
; 21(5): 411-25, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26218189
7.
Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial.
Cancer
; 121(11): 1873-81, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25809235
8.
A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up.
Breast Cancer Res Treat
; 154(2): 319-28, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26518021
9.
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer.
Breast Cancer Res Treat
; 147(2): 433-41, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012857
10.
Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
Breast Cancer Res Treat
; 148(1): 117-23, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25262341
11.
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.
Breast Cancer Res Treat
; 146(2): 321-8, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24699910
12.
Circulating tumor cells in breast cancer.
J Carcinog
; 13: 8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25191136
13.
Sleep quality and fatigue after a stress management intervention for women with early-stage breast cancer in southern Florida.
Int J Behav Med
; 21(6): 971-81, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24318654
14.
Molecularly targeted therapies for metastatic triple-negative breast cancer.
Breast Cancer Res Treat
; 138(1): 21-35, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23358903
15.
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 137(1): 187-93, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23143283
16.
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 139(3): 759-67, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23756626
17.
Systemic therapy options in BRCA mutation-associated breast cancer.
Breast Cancer Res Treat
; 135(2): 355-66, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22791366
18.
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer.
Breast Cancer Res Treat
; 132(2): 747-51, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22200867
19.
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab.
Breast Cancer Res Treat
; 132(3): 781-91, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21373875
20.
Bevacizumab in the treatment of metastatic breast cancer: friend or foe?
Curr Oncol Rep
; 14(1): 1-11, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22012632